Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 13/20 | 0.70 |
| ▸ | MMP3 | P08254 | 12/20 | 0.70 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.41 |
| ▸ | CDK9 | P50750 | 3/20 | 0.41 |
| ▸ | QDPR | P09417 | 1/20 | 0.41 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6590304 | 0.93 | MMP2 (0.69) | MMP2MMP3CCNT1CDK9QDPR | |
| SCHEMBL6586433 | 0.91 | MMP2 (0.85) | MMP2MMP3CCNT1CDK9ADAM10 | |
| SCHEMBL6587364 | 0.91 | MMP2 (0.63) | MMP2MMP3CCNT1CDK9QDPR | |
| SCHEMBL6586229 | 0.84 | MMP2 (0.59) | MMP2MMP3CCNT1CDK9QDPR | |
| SCHEMBL6590619 | 0.83 | MMP2 (0.65) | MMP2MMP3CCNT1CDK9QDPR | |
| SCHEMBL6588532 | 0.83 | MMP2 (0.84) | MMP2MMP3CCNT1CDK9MMP9 | |
| SCHEMBL6586903 | 0.83 | MMP3 (1.00) | MMP2MMP3ADAM10MMP9 | |
| SCHEMBL6586371 | 0.82 | MMP3 (0.77) | MMP2MMP3QDPR | |
| SCHEMBL6586646 | 0.81 | MMP2 (0.71) | MMP2MMP3CCNT1CDK9MMP9 | |
| SCHEMBL6590166 | 0.81 | MMP2 (0.84) | MMP2MMP3CCNT1CDK9DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |